TaskUs (NASDAQ:TASK – Get Free Report) will be announcing its earnings results after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of $0.30 per share for the quarter. TaskUs has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Investors that wish to register for the company’s conference call can do so using this link.
TaskUs (NASDAQ:TASK – Get Free Report) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.05. The firm had revenue of $234.26 million for the quarter, compared to the consensus estimate of $225.96 million. TaskUs had a net margin of 4.94% and a return on equity of 16.91%. On average, analysts expect TaskUs to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
TaskUs Price Performance
NASDAQ:TASK opened at $11.46 on Wednesday. The company has a market capitalization of $1.02 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 3.19 and a beta of 2.35. The company has a 50-day moving average of $11.85 and a 200-day moving average of $11.91. TaskUs has a 52 week low of $7.95 and a 52 week high of $14.67. The company has a debt-to-equity ratio of 0.58, a quick ratio of 3.23 and a current ratio of 3.23.
Wall Street Analyst Weigh In
Get Our Latest Stock Report on TASK
TaskUs Company Profile
TaskUs, Inc provides digital outsourcing services for companies in Philippines, the United States, India, and internationally. It offers digital customer experience that consists of omni-channel customer care services primarily delivered through non-voice digital channels; and other solutions, including experience and customer care services for new product or market launches, and customer acquisition solutions.
Further Reading
- Five stocks we like better than TaskUs
- 3 Stocks to Consider Buying in October
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Most Volatile Stocks, What Investors Need to Know
- Hilton Demonstrates Asset Light is Right for Investors
- How to Invest in Biotech Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for TaskUs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TaskUs and related companies with MarketBeat.com's FREE daily email newsletter.